TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
Authors:
- 1 February 2014
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 20 (2) , 66-71
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disordersHuman Molecular Genetics, 2013
- A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification studyThe Lancet Neurology, 2012
- Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALSNeuron, 2011
- TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosisNature Genetics, 2008
- TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral SclerosisScience, 2008
- TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosisBiochemical and Biophysical Research Communications, 2006
- Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral SclerosisScience, 2006
- Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17Nature, 2006
- Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21Nature, 2006
- Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing proteinNature Genetics, 2004